BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12748220)

  • 1. Clinical and angiographic acute and follow up results of intracoronary beta brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary beta brachytherapy (RENO).
    Schiele TM; Regar E; Silber S; Eeckhout E; Baumgart D; Wijns W; Colombo A; Rutsch W; Meerkin D; Gershlick A; Bonan R; Urban P;
    Heart; 2003 Jun; 89(6):640-4. PubMed ID: 12748220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre European registry of intraluminal coronary beta brachytherapy.
    Urban P; Serruys P; Baumgart D; Colombo A; Silber S; Eeckhout E; Gershlick A; Wegscheider K; Verhees L; Bonan R;
    Eur Heart J; 2003 Apr; 24(7):604-12. PubMed ID: 12657218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary beta-brachytherapy using a rhenium-188 filled balloon catheter in restenotic lesions of native coronary arteries and venous bypass grafts.
    Wöhrle J; Krause BJ; Nusser T; Mottaghy FM; Habig T; Kochs M; Kotzerke J; Reske SN; Hombach V; Höher M
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1314-20. PubMed ID: 16791596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study.
    Hoffmann R; Pohl T; Köster R; Blindt R; Boeckstegers P; Heitzer T
    Heart; 2007 Mar; 93(3):331-4. PubMed ID: 16940392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry.
    Kandzari DE; Goldberg S; Schwartz RS; Chazin-Caldie M; Sketch MH;
    Am Heart J; 2003 May; 145(5):868-74. PubMed ID: 12766746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy.
    Wöhrle J; Krause BJ; Nusser T; Kochs M; Höher M
    Cardiovasc Revasc Med; 2006; 7(1):2-6. PubMed ID: 16513516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use.
    Kim S; Almeda FQ; Tessalee M; Snell RJ; Nathan S; Thew S; Nguyen C; Chu JC; Schaer GL
    Cardiovasc Radiat Med; 2004; 5(1):9-14. PubMed ID: 15275626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility, safety, and preliminary efficacy of a novel ePTFE-covered self-expanding stent in saphenous vein graft lesions: the Symbiot II trial.
    Laarman GJ; Kiemeneij F; Mueller R; Guagliumi G; Cobaugh M; Serruys PW;
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):361-8. PubMed ID: 15736242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques.
    Al-Lamee R; Ielasi A; Latib A; Godino C; Ferraro M; Arioli F; Mussardo M; Piraino D; Figini F; Carlino M; Montorfano M; Chieffo A; Colombo A
    Am J Cardiol; 2010 Dec; 106(12):1721-7. PubMed ID: 21126616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
    Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic predictors of 6-month patency of bypass grafts implanted to the right coronary artery a prospective randomized comparison of gastroepiploic artery and saphenous vein grafts.
    Glineur D; D'hoore W; El Khoury G; Sondji S; Kalscheuer G; Funken JC; Rubay J; Poncelet A; Astarci P; Verhelst R; Noirhomme P; Hanet C
    J Am Coll Cardiol; 2008 Jan; 51(2):120-5. PubMed ID: 18191734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of intracoronary beta-brachytherapy administered by 60 mm transfer device/radiation source train: a subgroup analysis from the RENO registry.
    Jain D; Lorenzen HP; Hartmann F; Wegscheider K; Bonan R; Urban P; Schunkert H;
    J Invasive Cardiol; 2004 Jul; 16(7):363-7. PubMed ID: 15282429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and angiographic one-year follow-up of vascular beta-brachytherapy for coronary lesions treated by a stent with a very high risk for restenosis].
    Schiele TM; Pöllinger B; Kantlehner R; Dühmke E; Theisen K; Klauss V
    Dtsch Med Wochenschr; 2003 May; 128(20):1103-8. PubMed ID: 12748899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stent implantation of saphenous vein graft aorto-ostial lesions in patients with unstable ischemic syndromes: immediate angiographic results and long-term clinical outcome.
    Rechavia E; Litvack F; Macko G; Eigler NL
    J Am Coll Cardiol; 1995 Mar; 25(4):866-70. PubMed ID: 7884089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumen loss in the first year in saphenous vein grafts is predominantly a result of negative remodeling of the whole vessel rather than a result of changes in wall thickness.
    Lau GT; Ridley LJ; Bannon PG; Wong LA; Trieu J; Brieger DB; Lowe HC; Freedman BS; Kritharides L
    Circulation; 2006 Jul; 114(1 Suppl):I435-40. PubMed ID: 16820615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary beta-brachytherapy in chronic total occlusions: a subgroup analysis from the RENO registry.
    Jain D; Geist V; Lorenzen HP; Hartmann F; Wegscheider K; Bonan R; Urban P; Richardt G;
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):322-9. PubMed ID: 12594695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
    Hougaard M; Thayssen P; Kaltoft A; Tilsted HH; Maeng M; Lassen JF; Thuesen L; Okkels Jensen L
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1035-42. PubMed ID: 24311384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reno, a European postmarket surveillance registry, confirms effectiveness of coronary brachytherapy in routine clinical practice.
    Coen V; Serruys P; Sauerwein W; Orecchia R; Von Rottkay P; Coucke P; Ehnert M; Urban P; Bonan R; Levendag P;
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1019-26. PubMed ID: 12605982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting.
    Rodés-Cabau J; Facta A; Larose E; DeLarochellière R; Déry JP; Nguyen CM; Roy L; Proulx G; Gleeton O; Barbeau G; Noël B; Rouleau J; Boudreault JR; Bertrand OF
    Am J Cardiol; 2007 Aug; 100(4):640-5. PubMed ID: 17697821
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.